Baird reiterates an 'Outperform' rating on Gilead Sciences (Nasdaq: GILD). Price target lowered from $57 to $54.

Baird ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE